Obesity
Showing NaN - NaN of 95
Obesity, Overweight and Obesity Trial in United States (LY3305677, Placebo)
Not yet recruiting
- Obesity
- Overweight and Obesity
- LY3305677
- Placebo
-
Mesa, Arizona
- +23 more
Nov 6, 2023
Drug Utilisation of Mysimba/Contrave
Completed
- Obesity
-
Nashville, TennesseeCurrax Pharmaceuticals
Oct 17, 2023
Obesity, Metabolic Syndrome Trial in Nashville (Empagliflozin 25 MG, Placebo)
Not yet recruiting
- Obesity
- Metabolic Syndrome
- Empagliflozin 25 MG
- Placebo
-
Nashville, TennesseeVanderbilt University Medical Center
Jul 24, 2023
Obesity Trial in United States (AGBS)
Recruiting
- Obesity
- AGBS
-
Scottsdale, Arizona
- +11 more
Jan 9, 2023
Insulin Resistance, Healthy, Obesity Trial in Nashville (Phentolamine, Saline, Sodium Nitroprusside)
Recruiting
- Insulin Resistance
- +2 more
- Phentolamine
- +2 more
-
Nashville, TennesseeAutonomic Dysfunction Center
Jan 2, 2023
Overweight, Obesity Trial in Worldwide (Semaglutide, Placebo (semaglutide))
Active, not recruiting
- Overweight
- Obesity
- Semaglutide
- Placebo (semaglutide)
-
Birmingham, Alabama
- +804 more
Dec 19, 2022
Obesity Trial in Nashville (Oral Glucose Tolerance Test (OGTT), Human Ghrelin, Saline)
Active, not recruiting
- Obesity
- Oral Glucose Tolerance Test (OGTT)
- +2 more
-
Nashville, TennesseeVanderbilt University Medical Center
Nov 18, 2022
Overweight, Obesity Trial in Worldwide (Gelesis100, )
Completed
- Overweight
- Obesity
- Gelesis100
- placebo
-
Anaheim, California
- +35 more
Aug 8, 2022
Beige Fat, Energy, and the Natriuretic Peptide System
Recruiting
- Obesity
-
Nashville, Tennessee
- +1 more
Jul 1, 2022
Obesity Trial in Nashville (COACH, School Readiness Intervention)
Recruiting
- Obesity
- COACH
- School Readiness Intervention
-
Nashville, TennesseeVanderbilt University Medical Center
Jun 20, 2022
Obesity, Hypertension Trial in Nashville (Amlodipine, Moxonidine, Placebo)
Recruiting
- Obesity
- Hypertension
- Amlodipine
- +2 more
-
Nashville, TennesseeVanderbilt University Medical Center
Jun 8, 2022
Obesity Trial in Nashville (benzocaine, )
Enrolling by invitation
- Obesity
- benzocaine
- placebo
-
Nashville, TennesseeVanderbilt University Medical Center
Mar 29, 2022
Obesity Trial in Nashville (Tadalafil 20 MG, Placebo)
Recruiting
- Obesity
- Tadalafil 20 MG
- Placebo
-
Nashville, TennesseeVanderbilt University Medical Center
Mar 29, 2022
Obesity, Cardiovascular Physiological Phenomena, Metabolism Trial in Nashville (recombinant human BNP (1-32), normal saline ())
Active, not recruiting
- Obesity
- +2 more
- recombinant human BNP (1-32)
- normal saline (placebo)
-
Nashville, Tennessee
- +1 more
Mar 23, 2022
Obesity, Overweight Trial in Worldwide (Tirzepatide, Placebo)
Active, not recruiting
- Obesity
- Overweight
- Tirzepatide
- Placebo
-
Huntington Park, California
- +64 more
Mar 22, 2022
Obesity, Pre-diabetes Trial in Nashville (Empagliflozin 25 MG)
Completed
- Obesity
- Pre-diabetes
- Empagliflozin 25 MG
-
Nashville, TennesseeVanderbilt University Medical Center
Feb 12, 2022
Study of Changes in Skeletal Muscle After Caloric Restriction
Active, not recruiting
- Obesity
-
Nashville, TennesseeVanderbilt University Medical Center
Feb 24, 2022
Obesity, Cardiovascular Risk Factor, Salt; Excess Trial in Nashville (Low-salt diet, High-salt diet)
Recruiting
- Obesity
- +2 more
- Low-salt diet
- High-salt diet
-
Nashville, TennesseeVanderbilt University Medical Center
Feb 2, 2022
Gastroesophageal Reflux Disease, Obesity Trial in Nashville (Dietary Carbohydrate)
Active, not recruiting
- Gastroesophageal Reflux Disease
- Obesity
- Dietary Carbohydrate
-
Nashville, TennesseeTennessee Valley Healthcare System Nashville Campus, Nashville,
Jan 27, 2022
Obesity, Insulin Resistance, Hypertension Trial in Nashville (Angiotensin-(1-7), Saline)
Recruiting
- Obesity
- +3 more
-
Nashville, TennesseeVanderbilt University School of Medicine
Jan 18, 2022
Obesity Trial in Nashville (Normal Saline 0.9% Infusion Solution Bag)
Recruiting
- Obesity
- Normal Saline 0.9% Infusion Solution Bag
-
Nashville, TennesseeVanderbilt Univeristy
Jan 6, 2022